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1. Introduction 
Cytomegalovirus (CMV), a member of the herpes family which includes herpes simplex 
virus (HSV) 1 and 2, varicella zoster virus (VZV), and Epstein-Barr virus (EBV), is 
ubiquitous worldwide. About 85% of persons above the age of 40 in the general 
community are seropositive.1 CMV infections manifest more usually in 
immunocompromised individuals especially in patients with acquired immune deficiency 
syndrome (AIDS); however more recently, CMV infections have been reported in the 
immunocompetent person, manifesting as corneal endotheliitis as well as anterior uveitis 
associated with elevated intraocular pressure (IOP; hypertensive anterior uveitis).2-8 This 
chapter aims to review the ocular features and treatment of CMV anterior uveitis in the 
immunocompetent person. 
2. Pathophysiology 
Viruses are increasingly being implicated as a cause of what was previously considered to 
be idiopathic ocular inflammations in immunocompetent patients. CMV and HSV have 
been associated with Possner-Schlossman Syndrome (PSS)4,9,10 and rubella and HSV have 
been associated with Fuchs Heterochromic Iridocyclitis (FHI).11-13 In various studies, the 
presence of CMV deoxyribonucleic acid (DNA) has been identified in 41.7% of FHI and 
52.8% of PSS eyes.14 
The overlap between the different viruses and the variability in clinical presentations do 
suggest that ocular manifestations of viral diseases in immunocompetent patients may not 
be specific to a particular virus but rather a response to the viral infection based on the 
individual’s genetic make-up and immune status.14  
These viruses share common characteristics. The core contains a linear double-stranded 
DNA, which is surrounded by a capsid and an envelope. The envelope is a derivative of the 
core membrane of the infected cells and consists of lipids with inserted viral glycoprotein. 
There are specific receptors of the glycoproteins of the envelope that recognize 
complementary receptors on the host cell membrane and bind to them by adsorption. The 
envelope and the cell membrane fuse while the viral nucleocapsid enters the cell. The viral 
proteins are then produced in a cascade. The synthesis of DNA and assembly of capsid take 
place in the nucleus while the production of infected particles in the cytoplasm leads to 
destruction of the host cell.15-16 Viral DNA has been detected in monocytes, dendritic cells, 
megakaryocytes, and myeloid progenitor cells in the bone marrow.  
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Herpetic viruses are well known for their ability to cause keratitis, anterior uveitis, scleritis, 
and retinitis.17-19 Anterior uveitis is unilateral and typically has a chronic and/or recurrent 
character. Intraocular pressure (IOP) elevation, keratitis, endotheliitis, and stromal iris 
atrophy commonly accompany it. The iris stroma is infiltrated with lymphocytes, and an 
increase in IOP is typically seen on activation of the uveitis, probably due to an outflow 
obstruction. This outflow obstruction can be explained by both a viral trabeculitis with 
swelling of the trabecular cells and an obstruction of the trabecular meshwork by 
inflammatory debris.18-19  
The pathogenesis of CMV uveitis, although not completely understood, is believed to 
include various mechanisms such as viral replication, ischemic vasculitis, lymphocytic 
infiltration of the iris stroma or intraocular nerves. In addition, persistent and recurrent viral 
infection may cause an inflammatory reaction manifested as uveitis, or can trigger the 
immune system itself against viral antigens, eventually causing tissue and organ 
inflammation and damage.20-24 
3. Ocular features 
CMV in the anterior segment is a newly described entity that occurs even in people who are 
not infected with the human immunodeficiency virus (HIV). 
CMV infection can cause a spectrum of ocular manifestations, varying in severity from a 
mild self-limiting iritis with sector iris atrophy,6 to features of PSS,4-9 to the more chronic 
form resembling FHI, or even corneal endotheliitis.7 Two common features seen in these 
eyes with CMV uveitis are elevated IOP and iris atrophy. These features are consistent with 
the finding of CMV in the smooth muscle cells of the iris, the ciliary body, and the 
endothelial cells of the Schlemm canal.17  
In an analysis of published studies of non-HIV, CMV-associated anterior uveitis in 
immunocompetent patients, researchers found clinical presentations including endotheliitis, 
recurrent acute anterior uveitis and ocular hypertension, and chronic anterior uveitis.12 Eyes 
with such CMV-associated anterior uveitis usually have no corneal scars, no posterior 
synechiae, no flare or fibrin and no posterior segment involvement. 
Corneal endotheliitis may be unilateral or bilateral, typically causes blurred vision and is 
associated with corneal edema, Descemet’s folds, as well as fine and medium keratic 
precipitates that may be pigmented. Other associated clinical signs include iris atrophy, 
mild anterior chamber activity, reduced endothelial cell count, elevated IOP, coin-like 
lesions and the “owl eye sign” on confocal microscopy, representing inclusion bodies and 
macrophages. 
As mentioned, CMV can present clinically as PSS or FHI. PSS and FHI are 2 separate clinical 
entities that are similar in some aspects, but yet have important distinguishing features. 
Both have elevated intraocular pressures during the episodes of acute iritis (hypertensive 
anterior uveitis). Both have only a mild non-granulomatous anterior chamber activity with 
no posterior synechiae formation. However, PSS is an acute, intermittent, recurrent 
glaucomatocyclitic crisis with few keratic precipitates, while FHI is a chronic iridocyclitis 
with diffuse, fine, stellate keratic precipitates and may have vitritis. Exact aetiology of both 
conditions is still arguable although the consensus is that they are attributable to viruses 
including CMV as mentioned above.  
PSS is usually unilateral, with symptoms of redness, blurring, haloes and unilateral 
headache. Clinical features include elevated IOP, anterior chamber cells (grades ½ to 2+) 
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and fine to medium keratic precipitates either in a ring or linear pattern. Diffuse and patchy 
iris stromal atrophy is common. 
FHI may be unilateral or bilateral. The main symptom is blurred vision. Clinical features 
include elevated IOP, anterior chamber cells (grades 1 to 2+), fine feathery, diffuse keratic 
precipitates and diffuse “moth-eaten” iris atrophy. 
From literature data to date, 110 eyes of 106 non-HIV positive patients with CMV anterior 
segment infection have been described4-9 of which 27 eyes of 24 patients had endotheliitis, 57 
eyes had acute recurrent anterior uveitis and the remaining had chronic anterior uveitis. All 
the 83 anterior uveitis eyes and 24 of the endotheliitis eyes had ocular hypertension. 
4. Diagnosis 
The usefulness of aqueous humor sampling has been established in both anterior uveitis and 
posterior uveitis. A number of recent studies have shown the benefit of aqueous humor 
polymerase chain reaction (PCR) for the diagnosis of infectious uveitis and revealed a good 
degree of concordance between intraocular antibody and real-time PCR. Testing for DNA 
tends to be positive at the outset (and/or early at reactivation) and antibody testing can be 
positive at any point in time.25 A positive test result indicates at the most that the virus may 
be involved, but is by no means conclusive. A negative test does not exclude the herpes 
virus as a cause of the uveitis either. 
A minimum of 100 μl aqueous should be obtained via a diagnostic anterior chamber 
paracentesis and the samples must be delivered to the laboratory at 18 to 25 degrees Celsius 
within one hour or stored and transported at 2 to 4 degrees Celsius within 24 hours. The 
samples should be aliquoted immediately on arrival at the laboratory and used for DNA 
extraction immediately or kept at −20 degrees Celsius and used for DNA extraction within 
one week. 
Diagnostic anterior chamber paracentesis should involve the use of a 27-gauge needle 
inserted into the temporal, perilimbal, inferior one-third of the cornea; directed downwards 
while avoiding the lens. This has been shown to be a simple and safe office procedure.26 
Identification of the CMV virus makes it possible to institute the appropriate antiviral 
medication.  
5. Treatment 
Management of CMV anterior uveitis may involve the use of topical non-steroidal anti-
inflammatory agents, topical steroids, topical anti-glaucoma medications and topical or 
systemic antivirals. Patients should also be co-managed by the infectious disease physician 
to exclude systemic cytomegalovirus infections and other forms of immunocompromised 
states.  
Topical non-steroidal anti-inflammatory agents have been employed in the immediate 
setting to reduce ocular inflammation and treat the patient symptomatically. This is 
especially useful when the use of topical steroids is delayed intentionally till after the 
diagnostic anterior chamber paracentesis to allow better yield of viral DNA load when 
performing aqueous sampling.  
Topical steroids alone may be able to reduce the inflammation and IOP in a minority of 
cases. More commonly, combination with anti-glaucoma medication will give rise to more 
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effective lowering of IOP. However, steroids may cause steroid-induced glaucoma as a side 
effect. This is especially seen in patients who are on steroids for a long duration.  
Glaucoma therapy can be initiated in a stepwise manner in the following order, unless there 
are any contraindications to the medication: ǃ-blocker, ǂ-2 agonists, topical acetazolamide, 
and lastly, prostaglandin analogs. If the IOP exceeds 40 mm Hg, systemic acetazolamide can 
be considered. The medications when tailed down should be reduced in a stepwise manner 
as well, but in reverse order. 
Mydriatics or cycloplegics can be used as an adjunct to relieve any ciliary spasm, stabilize 
the blood aqueous barrier and assist in fundal evaluation. 
The main mode of antiviral therapy in these eyes has been systemic ganciclovir or 
valganciclovir.5-8,14,27-28 Some authors have also used intravitreal injections of ganciclovir28 or 
ganciclovir gel14 with variable outcomes. In many cases, the inflammation resolved with 
therapy, only to recur on cessation of treatment.5-7 Although there is no consensus as to 
which route of administration is most suitable, topical ganciclovir gel has been shown to 
produce less number of recurrences as compared to systemic gangciclovir.29  
Response to therapy in eyes with chronic anterior uveitis can be defined as the clinical 
resolution of anterior chamber cells and keratic precipitates and good IOP control with or 
without glaucoma medications while on treatment. In eyes with acute recurrent anterior 
uveitis, response can be defined as absence of recurrence of inflammation and normalisation 
of IOP without glaucoma medications other than that given during the acute episode while 
on treatment. 
All treated eyes responded to therapy, in terms of the severity of the inflammation and IOP 
control, to the initial antiviral treatment. However, 77.7% relapsed within eight months after 
stopping treatment, according to the experience of some authors.6,29 This indicates that CMV 
anterior uveitis may require a longer period of treatment, perhaps similar to that of herpetic 
uveitis or even other methods of treatment. 
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